LabCorp and its Specialty Testing Group, a fully integrated portfolio of specialty and esoteric testing laboratories.
To detect an abnormal testosterone level in males and females; in males, to help diagnose the cause of erectile dysfunction or the inability of your partner to get pregnant (infertility); in females, to help diagnose the cause of masculine physical features (virilization), infertility, or polycystic ovary syndrome (PCOS); in children, to help determine the cause of genitals that are not clearly male or female (ambiguous genitalia) or delayed or early puberty
A blood sample drawn from a vein in your arm; a morning sample is preferred.
Testosterone is the main sex hormone (androgen) in men. It is responsible for male physical characteristics. Although it is considered to be a "male" sex hormone, it is present in the blood of both men and women. This test measures the level of testosterone in the blood.
Testosterone is mainly produced by special endocrine tissue (the Leydig cells) in the male testicles. It is also produced by the adrenal glands in both males and females and, in small amounts, by the ovaries in females.
In males, testosterone stimulates development of secondary sex characteristics, including enlargement of the penis, growth of body hair, muscle development, and a deepening voice. It is present in large amounts in males during puberty and in adult males to regulate the sex drive and maintain muscle mass. In women, testosterone is converted to estradiol, the main sex hormone in females.
Testosterone production is stimulated and controlled by luteinizing hormone (LH), which is manufactured by the pituitary gland. Testosterone works within a negative feedback mechanism: as the testosterone level increases, LH production decreases, which slows testosterone production; decreased testosterone causes increased production of LH, which in turn stimulates testosterone production.
Testosterone levels are diurnal, peaking in the early morning hours (about 4:00 to 8:00 am), with the lowest levels in the evening (about 4:00 to 8:00 pm). Levels also increase after exercise and also decrease with age.
About two-thirds of testosterone circulates in the blood bound to sex-hormone binding globulin (SHBG) and slightly less than one-third bound to albumin. A small percent (less than 4%) circulates as free testosterone. The free plus the albumin-bound testosterone is the bioavailable fraction, which can act on target tissues.
In many cases, measurement of total testosterone provides a healthcare practitioner with adequate information. However, in certain cases, for example when the level of SHBG is abnormal, a test for free or bioavailable testosterone may be performed as it may more accurately reflect the presence of a medical condition.
A blood sample is taken by needle from a vein in the arm.
No test preparation is needed.
Testosterone testing is used to diagnose several conditions in men, women, girls, and boys. Testosterone is the main sex hormone in men, produced mainly by the testicles, and is responsible for male physical characteristics. Although it is considered to be a "male" sex hormone, it is present in the blood of both males and females.
The testosterone test may be used to help evaluate conditions such as:
Typically, a test for total testosterone is used for diagnosis. The total testosterone test measures testosterone that is bound to proteins in the blood (e.g., albumin and sex-hormone binding globulin [SHBG]) as well as testosterone that is not bound (free testosterone).
About two-thirds of testosterone circulates in the blood bound to SHBG and slightly less than one-third bound to albumin. A small percent (less than 4%) circulates as free testosterone. Free testosterone plus the testosterone bound to albumin is the bioavailable testosterone, which can act on target tissues.
In many cases, the total testosterone test provides adequate information. However, in certain cases, for example when the level of SHBG is abnormal, a test for free or bioavailable testosterone may be performed as it may more accurately reflect the presence of a medical condition.
Depending on the reason for testing, other tests and hormone levels may be done in conjunction with testosterone testing. Some examples include:
In men, the test may be ordered when infertility is suspected or when a man has a decreased sex drive or erectile dysfunction. Some other symptoms include lack of beard and body hair, decreased muscle mass, and development of breast tissue (gynecomastia). Low levels of total and bioavailable testosterone have also been associated with, or caused by, a greater presence of visceral fat (midriff or organ fat), insulin resistance, and increased risk of coronary artery disease.
In boys with delayed or slowly progressing puberty, the test is often ordered with the FSH and LH tests. Although there are differences from individual to individual as to when puberty begins, it is generally by the age of 10 years. Some symptoms of delayed puberty may include:
The test also can be ordered when a young boy seems to be undergoing a very early (precocious) puberty with obvious secondary sex characteristics. Causes of precocious puberty in boys, due to increased testosterone, include various tumors and congenital adrenal hyperplasia.
In females, testosterone testing may be done when a woman has irregular or no menstrual periods (amenorrhea), is having difficulty getting pregnant, or appears to have masculine features, such as excessive facial and body hair, male pattern baldness, and/or a low voice. Testosterone levels can rise because of tumors that develop in either the ovary or adrenal gland or because of other conditions, such as polycystic ovarian syndrome (PCOS).
The normal range for testosterone levels in men is broad and varies by stage of maturity and age. It is normal for testosterone levels to slowly decline, usually after age 30. Testosterone may decrease more in men who are obese or chronically ill and with the use of certain medications.
A low testosterone level (hypogonadism) may be due to:
Men who are diagnosed with consistently low testosterone levels and have related signs and symptoms may be prescribed testosterone replacement therapy by their healthcare providers. However, testosterone supplements are not approved by the Food and Drug Administration to boost strength, athletic performance, or prevent problems from aging. Use for these purposes may be harmful. For more information, see the Hormone Health Network article: The Truth about Testosterone Treatments.
Increased testosterone levels in males can indicate:
In women, testosterone levels are normally low. Increased testosterone levels can indicate:
Alcoholism and liver disease in males can decrease testosterone levels. Drugs, including androgens other than testosterone and steroids, can also decrease testosterone levels.
Prostate cancer responds to androgens, so many men with advanced prostate cancer receive drugs that lower testosterone levels.
Drugs such as anticonvulsants, barbiturates, and clomiphene can cause testosterone levels to rise. Women taking estrogen therapy may have increased total testosterone levels.
Maybe. Testosterone supplements, either with gels, patches or injections, can raise testosterone levels. They may help to relieve some symptoms and/or prevent muscle and bone loss that occurs with aging in men; however, this has not been definitively proven. There is concern that testosterone replacement therapy may exacerbate preexisting prostate cancer, but no evidence of causing cancer. There are label warnings that testosterone administration may result in possible increased risk of heart attack and stroke. Although men with erectile dysfunction may have low testosterone, in many cases testosterone administration does not improve the symptoms because there are other underlying conditions. Therefore, consult a healthcare practitioner for a medical evaluation and consultation to determine if this is the right therapy for you. Also read the Hormone Health Network infographic: The Truth About Testosterone Therapy.
Women's bodies also produce testosterone but in small amounts. It is needed for hormonal balance and to help women's bodies to function normally. If your body is producing too much testosterone, you may have more body hair than average, have abnormal or no menstrual periods, or be infertile. A testosterone test, in conjunction with measuring other hormone levels, can help your healthcare provider to understand what is causing your symptoms.
The amount, color, and texture of hair is largely determined by genetics. Studies have shown a proportional relationship of testosterone levels to the amount of body hair. The hair growth response to testosterone differs in different parts of the body. Hence, in some men, for example, testosterone promotes hair growth in the abdomen and back while hair growth is suppressed in the scalp, leading to male pattern baldness. Genetics plays a major role in the expression of the enzyme 5-alpha reductase, which converts testosterone to the hair-altering compound dihydrotestosterone, leading to a family tendency towards balding. The drug finasteride (Propecia®) inhibits the action of 5-alpha reductase and can reverse male pattern baldness in some men.
Testosterone is present in the blood as "free" testosterone (less than 4%) or bound testosterone (~98%). The latter may be loosely bound to albumin (about one-third), the main protein in the fluid portion of the blood, or bound to a specific binding protein called sex hormone binding globulin or SHBG (about two-thirds). The percentages in the three fractions varies greatly. The binding between testosterone and albumin is not very strong and is easily reversed, so the term bioavailable testosterone (BAT) refers to the sum of free testosterone plus albumin-bound testosterone.
It is suggested that bioavailable testosterone represents the fraction of circulating testosterone that readily enters cells and better reflects the bioactivity of testosterone than does the simple measurement of serum total testosterone. Also, varying levels of SHBG can result in inaccurate measurements of bioavailable testosterone. Decreased SHBG levels can be seen in obesity, hypothyroidism, androgen use, and nephritic syndrome (a form of kidney disease). Increased levels are seen in cirrhosis, hyperthyroidism, and estrogen use. In these situations, measurement of free testosterone may be more useful.
Sources Used in Current Review
2016 review performed by Donald Walt Chandler, Exec. Director Endocrine Sciences, LabCorp.
S. Bhasin, G.R. Cunningham, F.J. Hayes, Task Force, Endocrine Society, et al. Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metabolism, 6 (2010) 2536–259.
Centers for Disease Control Hormone Standardization website(HoST). Available online at http://www.cdc.gov/labstandards/hs_standardization.html. Accessed February 2016.
W. Rosner, R.J. Auchus, R. Azziz, et al. Position statement: utility, limitations, and pitfalls in measuring testosterone: an endocrine society position statement. J Clin Endocrinol Metabolism, 92 (2007), Pp. 405–413.
Sartorius G, Spasevska S, Idan A, Turner L, Forbes E, Zamojska A, Allan CA, Ly LP, Conway AJ, McLachlan RI, Handelsman DJ. Serum testosterone, dihydrotestosterone and estradiol concentrations in older men self-reporting very good health: the healthy man study. Clin Endocrinol (Oxf). 2012 Nov;77(5):755-63. doi: 10.1111/j.1365-2265.2012.04432.
Conway G, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Franks S, Gambineri A, Kelestimur F, Macut D, Micic D, Pasquali R, Pfeifer M, Pignatelli D & Pugeat M . B O Yildiz on behalf of the ESE PCOS Special Interest Group. The polycystic ovary syndrome: a position statement from the European Society of Endocrinology. European Journal of Endocrinology 2014 171 P1–P29. (doi:10.1530/EJE-14-0253).
Sources Used in Previous Reviews
Clinical Chemistry: Theory, Analysis, Correlation. 3rd Edition. Lawrence A. Kaplan and Amadeo J. Pesce, St. Louis, MO. Mosby, 1996.
Clinical Chemistry: Principles, Procedures, Correlations. Michael L. Bishop, Janet L. Duben-Engelkirk, Edward P. Fody. Lipincott Williams & Wilkins, 4th Edition.
The Gale Encyclopedia of Childhood and Adolescence. Testosterone. Available online at http://www.findarticles.com/p/articles/mi_g2602.
Laurence M. Demers, PhD. Distinguished Professor of Pathology and Medicine, The Pennsylvania State University College of Medicine, The M. S. Hershey Medical Center, Hershey, PA.
Pagana K, Pagana T. Mosby's Manual of Diagnostic and Laboratory Tests. 3rd Edition, St. Louis: Mosby Elsevier; 2006, Pp 481-484.
(January 2006) The Hormone Foundation. Low Testosterone and Men's Health. PDF available for download at http://www.hormone.org/Resources/Reproduction/upload/bilingual_Testosterone.pdf. Accessed January 2009.
(January 2008) Eugster E, Palmert M, eds. The Hormone Foundation. Precocious Puberty. PDF available for download at http://www.hormone.org/Resources/Growth/upload/bilingual_precocious_puberty.pdf. Accessed January 2009.
Tietz Textbook of Clinical Chemistry and Molecular Diagnostics. Burtis CA, Ashwood ER, Bruns DE, eds. St. Louis: Elsevier Saunders; 2006.
(March 18, 2008) Holt E. MedlinePlus Medical Encyclopedia. Testosterone. Available online at http://www.nlm.nih.gov/medlineplus/ency/article/003707.htm. Accessed January 2009.
(December 9, 2008) Mayo Clinic. Male hypogonadism. Available online at http://www.mayoclinic.com/health/male-hypogonadism/DS00300. Accessed January 2009.
(June 7, 2012) Kaplowitz. Precocious Puberty. Medscape Reference article. Available online at http://emedicine.medscape.com/article/924002-overview. Accessed November 2012.
(June 6, 2012) Kemp S. Hypogonadism. Medscape Reference. Available online at http://emedicine.medscape.com/article/922038-overview. Accessed November 2012.
(October 30, 2012) Lucidi R. Polycystic Ovarian Syndrome. Medscape Reference. Available online at http://emedicine.medscape.com/article/256806-overview. Accessed November 2012.
The Endocrine Society's Clinical Guidelines. Testosterone Therapy in Adult Men with Androgen Deficiency Syndromes. J Clin Endocrinol Metab June 2010, 95(6):2536–2559. PDF available for download at http://www.endo-society.org/guidelines/final/upload/FINAL-Androgens-in-Men-Standalone.pdf. Accessed November 2012.
Harrison's Principles of Internal Medicine, 18ed, Longo DL, Fauci AS, Kasper DL, Hauser SL, Jameson JL, Loscalzo J, Eds., McGraw-Hill. (2012) Chapters 49 & 346.